Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers

Klin Padiatr. 2015 Jul;227(4):225-31. doi: 10.1055/s-0034-1398689. Epub 2015 Jun 9.

Abstract

Background: Progressive cardiomyopathy (CMP) is one main cause of death in DMD. This cross-sectional assessment of different cardiac diagnostic procedures focusses on preterm diagnosis of cardiac dysfunction.

Patients: 39 male DMD patients aged 6-20 years were included. 6 patients were still ambulatory, 21 patients received corticosteroid therapy.

Methods: All patients were investigated by ECG, Holter ECG and heart rate variability (HRV), B-type natriuretic peptide (BNP), echocardiography (TTE), tissue Doppler Imaging (TD) and magnetic resonance imaging (MRI) with Late Gadolinium enhancement (LE) and segmental wall motion analysis (WMA).

Results: 56% of the patients showed repolarization abnormalities and 76% altered HRV. Subnormal ventricular function was found in 25% by TTE and in 34% by MRI. TD differed from normal controls only in the apical septum. In MRI 89% of the patients showed different distribution and intensity of LE and WM restriction. The extent of LE was less in patients after steroid treatment (p<0.05).

Discussion: MRI with segmental LE- and WM-analysis seems to be superior to TTE and TD in exploring regional distribution and severity of damage of the myocardium. ECG and HRV abnormalities are common in DMD-patients but not tightly predictive for segmental and global left ventricular dysfunction. Targeted treatment of CMP in DMD needs prospective evaluation.

Conclusion: A timely cardiac MRI is the most sensitive investigation for the identification of early myocardial changes in DMD which is a prerequisite for early interventions and therapeutic strategies.

MeSH terms

  • Adolescent
  • Autonomic Nervous System Diseases / diagnosis
  • Autonomic Nervous System Diseases / physiopathology
  • Cardiomyopathies / diagnosis*
  • Cardiomyopathies / physiopathology*
  • Child
  • Contrast Media / pharmacokinetics
  • Diagnostic Imaging*
  • Echocardiography, Doppler
  • Elasticity Imaging Techniques
  • Electrocardiography*
  • Electrocardiography, Ambulatory*
  • Heart Rate / physiology*
  • Hemodynamics / physiology
  • Heterocyclic Compounds / pharmacokinetics
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Muscular Dystrophy, Duchenne / diagnosis*
  • Muscular Dystrophy, Duchenne / physiopathology*
  • Myocardial Contraction / physiology*
  • Natriuretic Peptide, Brain / blood*
  • Organometallic Compounds / pharmacokinetics
  • Reference Values
  • Young Adult

Substances

  • Contrast Media
  • Heterocyclic Compounds
  • Organometallic Compounds
  • Natriuretic Peptide, Brain
  • gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate